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Chemical (ATC-2012edition) System. A systematic approach was also used to 
compare national results of the current study to similar results of other coun-
tries. Results: More than 425 million prescriptions were reviewed. The total price 
of antidepressant prescription and dispensation was about 40 million and 210 mil-
lion US$ respectively. The most frequently prescribed medicines were nortriptyline, 
fluoxetine, and citalopram, which were accounted for 63% of all prescriptions. 87 
articles were retrieved from various databases and other sources after excluding the 
duplicated articles. 17 articles were screened by titles and abstracts. After excluding 
the non relevant studies, there were 6 articles remained which were eligible for full 
text assessment. ConClusions: In compliance with the global trend, there was a 
growing tendency obviously observed towards prescribing SSRIs in Iran. In the face 
of rising burden of depression, on the one hand and the rising cost of medication 
and lack of funding resources on the other hand, we need to adopt strategies for 
promoting rational antidepressant medications use. These finding has important 
value for priority setting in planning and implementation of strategies for promot-
ing rational drug use.
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objeCtives: To examine antidepressant prescription patterns in Japanese children 
and adolescents. Methods: We conducted a cross-sectional survey during October 
2013 on outpatients, aged 19 or less, in 34 private mental clinics. Patients who were 
prescribed at least one antidepressant were analyzed in this report. Data on gen-
der, age, principal psychiatric diagnosis (based on ICD-10), and types and doses of 
psychotropic drugs were extracted. Results: The samples consisted of 137 males 
and 170 females. The average age (standard deviation) was 16.2 years (2.5). The 
mean length of psychiatric treatment was 23.6 months (23.3). The most frequent 
diagnostic category was neurotic disorders (F4; n= 113), followed by mood disor-
ders (F3; n= 73), disorders of psychological development (F8; n= 67), behavioral and 
emotional disorders (F9; n= 22), schizophrenic spectrum disorders (F2; n= 18), and 
other diagnoses (n= 14). Among the 19 antidepressants available in Japan, the pre-
scription rate of fluvoxamine (42.3%; n= 130) was the highest, followed by sertraline 
(17.6%), duloxetine (10.4%), escitalopram (9.8%), trazodone (6.5%), and paroxetine 
(5.5%). Tricyclic or tetracyclic antidepressants (TCAs) were prescribed in 35 patients 
(11.4%). Two or more antidepressants were prescribed concurrently in 27 (8.8%) of 
the 307 patients. Anxiolytics/hypnotics were concurrently prescribed in 126 (41.0%). 
Mood stabilizers were co-prescribed in 35 (11.4%). Antipsychotics were concurrently 
prescribed in 134 (43.6%), with a median dose of 100mg/d chlorpromazine equiva-
lent. ConClusions: In Japan, although augmentation of antidepressant treatment 
seemed relatively popular with antipsychotics in adolescent patients, antipsychotic 
doses might be relatively low.
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objeCtives: Many factors including patient, physician, medicine promotion and 
price affect prescribing of a medicine. The present study is aimed at showing the 
parameters that affect prescription writing and determine the effect of each of 
them on prescription process in Iran. Methods: In order to investigate the effect 
of price, advertisement, gender, and age on the sales and prescribing process 
of three medicines, namely fluvoxamine, clopidrogrel and latanoprosta, pooling 
data method in econometrics (Panel data) was used. Results: We found that 
advertisement and medicine insurance coverage had significant positive effects 
on prescription of all three medicines whilst negative relationship were seen 
between increasing price and the frequency of prescription of a medicine. Besides, 
we found out that advertisement has a direct effect on raising the demand and 
prescription of the medicines. ConClusions: Pharmaceutical companies need 
special attention to the index of physicians like age and sex in planning for sales 
and marketing of its products.
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objeCtives: Stigmatization associated with mental illnesses could prevent schiz-
ophrenic and people with major depression to access to health care. Stigma often 
varies depending on social contexts. A survey in this subject was conducted first 
in Germany, then in France and finally in Tunisia. The objective of current study 
is to describe public beliefs and attitudes about schizophrenia, major depres-
sion and psychotropic drugs in Tunisia. Methods: Three questionnaires were 
administered face-to-face to a representative sample of 1038 Tunisian people. 
415 persons answered a questionnaire on schizophrenia, 418 on major depression 
and 205 about psychotropic drugs. They were asked to address a validated ques-
tionnaire. Results: All 1038 questionnaires were fully completed. 38.8% (resp. 
26.8%) of people reported being not comfortable in presence of a schizophrenic 
patient (resp. major depression), while 33.7% (resp. 58.1%) reported they did. More 
than 89.9% (resp. 90.2%) felt the need to help people suffering from schizophrenia 
(resp. major depression), although 58.6% (resp. 43.3%) think that such patients 
are strange, and 29.6% (resp. 16.0%) think they are dangerous. 47.81% agree with 
the fact that psychotropic treatment helps people to better support the concerns 
chronic pain, while reducing their use of controlled medications. A larger follow-up 
study is needed to validate and expand on these preliminary findings.
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objeCtives: The purpose of this study was to assess health-related quality of life 
(HRQoL) and economic burden among outpatients with major depressive disorder 
(MDD) in regards to achieving remission. Methods: This was a nationwide cross-
sectional study. A total of 811 MDD patients over 18 years old were enrolled and 
each patient was allotted to one of three groups (1: 1: 1 ratio) as follow; new visit 
group (n= 287), remitted group (n= 235), and non-remitted group (n= 289). The 17-item 
Hamilton Depression Rating Scale (HAM-D) was used to assign patients to either 
remitted or non-remitted group. HRQoL was assessed with EuroQuol 5D (EQ-5D 
index score), EuroQuol Visual Analog Scale (EQ-VAS), and Quality of life Enjoyment 
and Satisfaction Questionnaire Short Form (Q-LES-Q-SF). To investigate the eco-
nomic burden of MDD patients, the total monthly costs (USD) were evaluated by sum 
of direct medical costs, direct non-medical costs (transportation and supplementary 
therapy), and indirect costs collected via patients interview. Indirect costs were 
measured by absenteeism and presenteeism utilizing the Korean version of World 
Health Organization Health and Work Performance Questionnaire (HPQ). Results: 
Non-remitted group showed statistically significant impairment of HRQoL as 
revealed by the results of EQ-5D index score, EQ-VAS, and Q-LES-Q-SF compared 
to remitted group (0.57±0.23 vs. 0.77±0.10, 50.9±20.34 vs. 72.5±16.59, 0.41±0.14 vs. 
0.58±0.16, respectively, p< 0.0001). Regarding direct medical costs, the non-remitted 
group incurred the highest costs compared to other groups (p< 0.0286). As of the 
indirect costs, remitted group demonstrated significant improvement in produc-
tivity when compared with other groups (p< 0.0001). Total monthly costs were the 
highest in non-remitted group (1187±857.8) compared to remitted group (766±684.5) 
and new visit group (1063±773.1), (p< 0.0001). ConClusions: Non-remitted MDD 
patients suffer from both lower HRQoL and higher economic burden compared 
with remitted group and new visit group. These results suggest the importance of 
achieving remission in Korean MDD patients.
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objeCtives: To determine the prevalence and predictors of cognitive impairment 
among older residents of nursing homes in the state of Penang, Malaysia. Methods: 
This multi-centred cross-sectional study was conducted in two phases over a six-
month period at four non-governmental nursing facilities in Penang, Malaysia. 
Older residents (≥ 65 years old) who were taking at least one medication and had 
not been previously diagnosed with dementia were included. Demographic and 
clinical data were collected through direct interviews and the review of medical 
records. Cognitive screening was performed using the Mini-Cog at baseline. Health 
Related Quality of Life (HRQOL) was assessed at baseline and after a three-month 
interval using the EuroQol (EQ-5D) and EQ Visual Analogue Scale (VAS). Results: 
The study included 211 residents with mean (SD) age of 77.7 (7.0) years and majority 
female residents, 128 (60.7%). Mini-Cog identified 129 (61%) residents with cognitive 
impairment. The three most common co-morbidities among the sample popula-
tion were hypertension (71.1%), diabetes mellitus (27.1%) and cerebral vascular 
disease (12.3%). Logistic regression analysis shown that longer formal education 
of more than six years (OR = 2.81, p = 0.007, 95% CI [0.167-0.757]) and inability to 
self-administer medications (OR = 3.29, p < 0.001, 95% CI [0.156-0.594]) significantly 
predicted cognitive impairment based on Mini-Cog score ≤ 2. However, Mini-Cog 
was not significantly associated with changes in HRQOL at three months follow-
up. ConClusions: We found a high prevalence of possible cognitive impairment 
among nursing home residence who had not been previously diagnosed, especially 
those who were unable to self-administer their medications. The length of formal 
education can be deceptive. Therefore, more vigilant screening should be performed 
for early detection and proper intervention of dementia although HRQOL is not 
affected by poor scoring in Mini-Cog.
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objeCtives: To assess the prescribing and usage pattern of antidepressant medi-
cations and the impact of their cost from 2007 to 2011 in Iran and to compare the 
results to other countries. Methods: A cross-sectional study was carried out on 
physicians’ prescription data based on the claims that the pharmacies submitted 
electronically to the insurers during 5 years from 2007 to 2011. Data related to 
dispensing of antidepressant were obtained from the official databank of national 
regulatory authority. Drugs were classified according to the Anatomic Therapeutic 
